WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its ...
Cash balance of $116 million as of June 30, 2026 expected to fund operations through the end of 2028, supporting anticipated ...
Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization ...
Denifanstat showed continued improvement and sustained efficacy across all efficacy endpoints through 52 weeks, including 57% ...
About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development of ...
(TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
Argenx shares have fallen more than 13% after the surprise futility finding, which overshadowed a mid-stage celiac disease ...
With the patent court siding with Halozyme, Merck faces restrictions on a product that won approval in Europe last year.
Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results